Growth In The Neonatal Point Of Care Testing Market Is Being Driven By Rising Demand For Remote Patient Monitoring Driving The Growth Of The Market Due To Increasing Access To Timely Newborn Care
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Neonatal Point Of Care Testing Market In 2026 And 2030?
The neonatal point of care testing market size has experienced swift expansion in recent years. It is projected to grow from $1.32 billion in 2025 to $1.52 billion in 2026, at a compound annual growth rate (CAGR) of 14.5%. The growth observed in the historic period can be ascribed to several factors, including increasing neonatal mortality awareness, the adoption of rapid testing devices in hospitals, government support for neonatal care, the expansion of maternity clinics, and technological improvements in bedside testing.
The neonatal point of care testing market size is projected to experience substantial growth over the next few years. It is expected to expand to $2.59 billion by 2030, achieving a compound annual growth rate (CAGR) of 14.3%. The drivers behind this growth in the forecast period include the rise of AI-based diagnostic solutions, cloud integration for neonatal data management, portable and compact point-of-care devices, increasing private-public partnerships in newborn health, and the growth in emerging economies’ neonatal healthcare infrastructure. Additionally, significant trends anticipated during this period feature AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, and the integration of IoT for newborn monitoring.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Neonatal Point Of Care Testing Market Landscape?
The anticipated rise in the demand for remote patient monitoring is set to stimulate the expansion of the neonatal point of care testing market in the future. Remote patient monitoring is defined as the delivery of medical services through technology, linking patients with healthcare providers remotely. The need for remote patient monitoring is escalating because of the growing requirement for easily accessible and convenient medical support, particularly for individuals in distant or poorly served regions. Neonatal point-of-care testing aids remote patient monitoring by delivering instant diagnostic results at the bedside, enabling healthcare professionals to promptly detect and address serious conditions in infants without the need for a centralized lab. As an illustration, a survey conducted by Vivalink, a US-based healthcare technology firm, in August 2023, indicated that 84% of existing remote patient monitoring (RPM) users plan to increase their usage in 2024, 45% of healthcare providers employ RPM for critical monitoring in hospital-at-home initiatives, and 77% anticipate RPM-driven care surpassing conventional inpatient hospital care within the next five years. Consequently, the heightened demand for remote patient monitoring is projected to fuel the expansion of the neonatal point of care testing market.
What Segment Categories Shape The Neonatal Point Of Care Testing Market Segment Landscape?
The neonatal point of care testing market covered in this report is segmented –
1) By Product: Instruments, Assay
2) By Test Type: Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, Other Test Types
3) By End-Users: Hospitals, Maternity And Specialty Clinics, Other End-Users
Subsegments:
1) By Instruments: Blood Gas Analyzers, Bilirubinometers, Glucose Meters
2) By Assay: Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, Blood Gas Assays
What Market Trends Are Affecting The Neonatal Point Of Care Testing Market?
Leading companies in the neonatal point of care testing market are concentrating on forging strategic collaborations to allow them to more efficiently access new markets and customer bases. Strategic collaborations are alliances among organizations that combine resources and expertise to accomplish mutual business objectives. For example, in January 2025, QIAGEN, a Netherlands-based supplier of sample and assay technologies, collaborated with Genomics England, a UK-based genomic medicine company. This partnership has led to the launch of the Generation Study, which will sequence the genomes of 100,000 newborns in England to screen for more than 200 actionable genetic conditions. QIAGEN will furnish unique clinically relevant variant information for the genes incorporated in the point-of-care sequencing test. This data will facilitate quicker interpretation and reporting of sequencing results, aiding in the earlier detection and treatment of rare conditions. Officially commencing in October 2024, the study targets conditions that might affect around 3,000 newborns annually in the UK.
Who Are The Companies Operating Across The Neonatal Point Of Care Testing Market Value Chain?
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl
Get The Full Neonatal Point Of Care Testing Market Report:
Which Region Leads The Neonatal Point Of Care Testing Market In Overall Market Size?
North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Neonatal Point Of Care Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Neonatal Point Of Care Testing Market 2026, By The Business Research Company
Pediatric And Neonatal Testing Kit Market Report 2026
Prenatal Testing And Newborn Screening Market Report 2026
Prenatal And Newborn Genetic Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
